Ransom Advisory’s Boston Scientific BSX Stock Holding History

Ransom Advisory’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$41K	Hold	430	–	–	0.02%	232
2025 Q3	$42K	Hold	430	–	–	0.02%	178
2025 Q2	$46.2K	Hold	430	–	–	0.02%	182
2025 Q1	$43.4K	Hold	430	–	–	0.02%	191
2024 Q4	$38.4K	Hold	430	–	–	0.02%	237
2024 Q3	$36K	Sell	430 -265	-38%	-$20.9K	0.02%	254
2024 Q2	$53.5K	Buy	+695	New	+$50.9K	0.03%	205

Other funds holding BSX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Ransom Advisory's BSX Position: Q4 2025 in Review

Ransom Advisory held its Boston Scientific (BSX) position steady in Q4 2025 at 430 shares worth $41K. The position accounts for 0.02% of the portfolio, ranked #232.

Ransom Advisory first reported a position in BSX in Q2 2024 and has held it in 7 quarters since. The position peaked at $53.5K in Q2 2024. 1,784 funds tracked by Wall St. Rank hold BSX as of Q4 2025.

Ransom Advisory held 430 shares of Boston Scientific worth $41K as of Q4 2025.
Ransom Advisory left its Boston Scientific share count unchanged in Q4 2025.
Boston Scientific made up 0.02% of Ransom Advisory's portfolio in Q4 2025, its #232 holding.
Ransom Advisory first reported a position in Boston Scientific in Q2 2024 and has held it in 7 quarters since.
Ransom Advisory's Boston Scientific position peaked at $53.5K in Q2 2024.
1,784 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2025.

Based on Ransom Advisory's 13F filing for Q4 2025, filed 6 Jan 2026.